Item Type | Name |
Concept
|
Adult
|
Concept
|
Young Adult
|
Academic Article
|
Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features.
|
Academic Article
|
Prognostic significance of repeat biopsy in lupus nephritis: Histopathologic worsening and a short time between biopsies is associated with significantly increased risk for end stage renal disease and death.
|
Academic Article
|
Adults with systemic lupus exhibit distinct molecular phenotypes in a cross-sectional study.
|
Academic Article
|
Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers.
|
Academic Article
|
Autoantibody-positive healthy individuals with lower lupus risk display a unique immune endotype.
|
Academic Article
|
Identification and characterization of a peptide mimetic that may detect a species of disease-associated anticardiolipin antibodies in patients with the antiphospholipid syndrome.
|
Academic Article
|
Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study.
|
Academic Article
|
Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus.
|
Academic Article
|
Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus.
|
Academic Article
|
Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus.
|
Academic Article
|
Evidence for gene-gene epistatic interactions among susceptibility loci for systemic lupus erythematosus.
|
Academic Article
|
Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort.
|
Academic Article
|
Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies.
|
Academic Article
|
Dysregulation of the microvasculature in nonlesional non-sun-exposed skin of patients with lupus nephritis.
|
Academic Article
|
Sex-specific differences in the relationship between genetic susceptibility, T cell DNA demethylation and lupus flare severity.
|
Academic Article
|
Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naïve CD4+ T cells from lupus patients.
|
Academic Article
|
Variable association of reactive intermediate genes with systemic lupus erythematosus in populations with different African ancestry.
|
Academic Article
|
25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort.
|
Academic Article
|
Efficacy and safety of abatacept in lupus nephritis: a twelve-month, randomized, double-blind study.
|
Academic Article
|
End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.
|
Academic Article
|
Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.
|
Academic Article
|
Renal involvement in lupus is characterized by unique DNA methylation changes in naïve CD4+ T cells.
|
Academic Article
|
Treatment of systemic lupus erythematosus patients with the BAFF antagonist "peptibody" blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials.
|
Academic Article
|
Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study.
|
Academic Article
|
Long-Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate-to- Severe Systemic Lupus Erythematosus: Results From an Open-Label Extension Study.
|
Academic Article
|
The frequency and outcome of lupus nephritis: results from an international inception cohort study.
|
Academic Article
|
Epigenetic Reprogramming in Naive CD4+ T Cells Favoring T Cell Activation and Non-Th1 Effector T Cell Immune Response as an Early Event in Lupus Flares.
|
Academic Article
|
Impact of heart rate variability, a marker for cardiac health, on lupus disease activity.
|
Academic Article
|
Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial.
|
Academic Article
|
Clinical and Serologic Features in Patients With Incomplete Lupus Classification Versus Systemic Lupus Erythematosus Patients and Controls.
|
Academic Article
|
Anifrolumab, an Anti-Interferon-a Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus.
|
Academic Article
|
Pathways of impending disease flare in African-American systemic lupus erythematosus patients.
|
Academic Article
|
Contribution of Socioeconomic Status to Racial/Ethnic Disparities in Adverse Pregnancy Outcomes Among Women With Systemic Lupus Erythematosus.
|
Academic Article
|
Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.
|
Academic Article
|
Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort.
|
Academic Article
|
Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies.
|
Academic Article
|
Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen.
|
Academic Article
|
Safety and Efficacy of Belimumab Plus Standard Therapy for Up to Thirteen Years in Patients With Systemic Lupus Erythematosus.
|
Academic Article
|
Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus Erythematosus.
|
Academic Article
|
The Spectrum of Health Domains Important to Lupus Patients Early Development of a Disease Activity Patient Reported Outcome.
|
Academic Article
|
Development and content validity of the Lupus Foundation of America rapid evaluation of activity in lupus (LFA-REALâ„¢): a patient-reported outcome measure for lupus disease activity.
|
Academic Article
|
Immunologic findings precede rapid lupus flare after transient steroid therapy.
|
Academic Article
|
Economic Evaluation of Damage Accrual in an International Systemic Lupus Erythematosus Inception Cohort Using a Multistate Model Approach.
|
Academic Article
|
Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus.
|
Academic Article
|
Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index.
|
Academic Article
|
High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin.
|
Academic Article
|
Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.
|
Academic Article
|
Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
|
Academic Article
|
IgG autoantibodies against beta2-glycoprotein I complexed with a lipid ligand derived from oxidized low-density lipoprotein are associated with arterial thrombosis in antiphospholipid syndrome.
|
Academic Article
|
Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study.
|
Academic Article
|
Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus.
|
Academic Article
|
Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study.
|
Academic Article
|
Plasma from systemic lupus patients compromises cholesterol homeostasis: a potential mechanism linking autoimmunity to atherosclerotic cardiovascular disease.
|
Academic Article
|
Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.
|
Academic Article
|
The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial.
|
Academic Article
|
Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus.
|
Academic Article
|
TAM receptor ligands in lupus: protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus.
|
Academic Article
|
Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups.
|
Academic Article
|
Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations.
|
Academic Article
|
Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort.
|
Academic Article
|
Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.
|
Academic Article
|
Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus.
|
Academic Article
|
Proinflammatory adaptive cytokine and shed tumor necrosis factor receptor levels are elevated preceding systemic lupus erythematosus disease flare.
|
Academic Article
|
Subcutaneous tocilizumab versus placebo in combination with disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
|
Academic Article
|
A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-a) in patients with systemic lupus erythematosus (ROSE).
|
Academic Article
|
Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
|
Academic Article
|
Gene Expression and Pharmacodynamic Changes in 1,760 Systemic Lupus Erythematosus Patients From Two Phase III Trials of BAFF Blockade With Tabalumab.
|
Academic Article
|
The Biomarkers of Lupus Disease Study: A Bold Approach May Mitigate Interference of Background Immunosuppressants in Clinical Trials.
|
Academic Article
|
Comparison of the Lupus Foundation of America-Rapid Evaluation of Activity in Lupus to More Complex Disease Activity Instruments As Evaluated by Clinical Investigators or Real-World Clinicians.
|
Academic Article
|
Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus: Results of a Twenty-Four-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Phase IIb Study.
|
Academic Article
|
Brief Report: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis.
|
Academic Article
|
Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.
|
Academic Article
|
Attainment of treat-to-target endpoints in SLE patients with high disease activity in the atacicept phase 2b ADDRESS II study.
|
Academic Article
|
Accrual of Atherosclerotic Vascular Events in a Multicenter Inception Systemic Lupus Erythematosus Cohort.
|
Academic Article
|
Frequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE.
|
Academic Article
|
Appropriate management of antiphospholipid-related pregnancy in women without lupus who have low titer autoantibodies.
|
Academic Article
|
Which antiphospholipid antibody tests are most useful?
|
Academic Article
|
Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.
|
Academic Article
|
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
|
Academic Article
|
Enhanced CD36 scavenger receptor expression in THP-1 human monocytes in the presence of lupus plasma: linking autoimmunity and atherosclerosis.
|
Academic Article
|
Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus.
|
Academic Article
|
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.
|
Academic Article
|
B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels.
|
Academic Article
|
Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials.
|
Academic Article
|
American College of Rheumatology criteria at inception, and accrual over 5 years in the SLICC inception cohort.
|
Academic Article
|
Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort.
|
Academic Article
|
Differential expression of the transcription factor ARID3a in lupus patient hematopoietic progenitor cells.
|
Academic Article
|
Genetic association of CD247 (CD3?) with SLE in a large-scale multiethnic study.
|
Academic Article
|
Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study.
|
Academic Article
|
Brief Report: Changes in Antiphospholipid Antibody Titers During Pregnancy: Effects on Pregnancy Outcomes.
|
Academic Article
|
A Longitudinal Analysis of Outcomes of Lupus Nephritis in an International Inception Cohort Using a Multistate Model Approach.
|
Academic Article
|
Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial.
|
Academic Article
|
Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort.
|
Academic Article
|
Longitudinal profiling of human blood transcriptome in healthy and lupus pregnancy.
|
Academic Article
|
Construction of a Frailty Index as a Novel Health Measure in Systemic Lupus Erythematosus.
|
Academic Article
|
Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.
|
Academic Article
|
Low frequency of flares during pregnancy and post-partum in stable lupus patients.
|
Academic Article
|
Prediction of Hospitalizations in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index.
|
Academic Article
|
Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: a randomized, double-blind, placebo-controlled trial.
|
Academic Article
|
Defining response in systemic lupus erythematosus: a study by the Systemic Lupus International Collaborating Clinics group.
|
Academic Article
|
Combined oral contraceptives in women with systemic lupus erythematosus.
|
Academic Article
|
Expression of endothelial protein C receptor in cortical peritubular capillaries associates with a poor clinical response in lupus nephritis.
|
Academic Article
|
A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus.
|
Academic Article
|
Novel evidence-based systemic lupus erythematosus responder index.
|
Academic Article
|
SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus.
|
Academic Article
|
Genome-wide DNA methylation patterns in CD4+ T cells from patients with systemic lupus erythematosus.
|
Academic Article
|
Safety profile and clinical activity of sifalimumab, a fully human anti-interferon a monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study.
|
Academic Article
|
Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus.
|
Academic Article
|
Monitoring cartilage loss in the hands and wrists in rheumatoid arthritis with magnetic resonance imaging in a multi-center clinical trial: IMPRESS (NCT00425932).
|
Academic Article
|
Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity.
|
Academic Article
|
Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.
|
Academic Article
|
Electrocardiographic findings in systemic lupus erythematosus: data from an international inception cohort.
|
Academic Article
|
Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA.
|
Academic Article
|
Disease activity in systemic lupus erythematosus correlates with expression of the transcription factor AT-rich-interactive domain 3A.
|
Academic Article
|
Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura.
|
Academic Article
|
Sifalimumab, an anti-interferon-a monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study.
|
Academic Article
|
Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity.
|
Academic Article
|
Brief Report: Longitudinal Patterns of Response to Standard of Care Therapy for Systemic Lupus Erythematosus: Implications for Clinical Trial Design.
|
Academic Article
|
Kidney Outcomes and Risk Factors for Nephritis (Flare/De Novo) in a Multiethnic Cohort of Pregnant Patients with Lupus.
|
Academic Article
|
The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients.
|
Academic Article
|
Two-year Efficacy and Safety of Subcutaneous Tocilizumab in Combination with Disease-modifying Antirheumatic Drugs Including Escalation to Weekly Dosing in Rheumatoid Arthritis.
|
Academic Article
|
Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study.
|
Academic Article
|
Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort.
|
Academic Article
|
Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
|
Academic Article
|
Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach.
|
Academic Article
|
Cancer Risk in a Large Inception Systemic Lupus Erythematosus Cohort: Effects of Demographic Characteristics, Smoking, and Medications.
|
Academic Article
|
Dynamic state of beta 2 integrin phosphorylation: regulation of neutrophil aggregation involves a phosphatase-dependent pathway.
|
Academic Article
|
High prevalence of antiphospholipid antibodies in patients taking procainamide.
|
Academic Article
|
Safety and clinical activity of atacicept in the long-term extension of the phase 2b ADDRESS II study in systemic lupus erythematosus.
|
Academic Article
|
Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: data from an international inception cohort.
|
Academic Article
|
Neuropsychiatric Events in Systemic Lupus Erythematosus: Predictors of Occurrence and Resolution in a Longitudinal Analysis of an International Inception Cohort.
|
Academic Article
|
Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
|
Academic Article
|
Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus.
|
Academic Article
|
Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus.
|